Dry Eye Syndrome Market Size

  • Report ID: 4587
  • Published Date: Sep 10, 2025
  • Report Format: PDF, PPT

Dry Eye Syndrome Market Outlook:

Dry Eye Syndrome Market size was valued at USD 6.4 billion in 2025 and is expected to reach USD 11.57 billion by 2035, registering around 6.1% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of dry eye syndrome is evaluated at USD 6.75 billion.

The growth of the market can primarily be ascribed to the rise in the number of people suffering with dry eye syndrome and higher spending on its treatment. Moreover, there has been a high prevalence from dry eyes owing to various other diseases such as thyroid disorders, diabetes, arthritis, and others, that is expected to boost the market’s growth in the upcoming years. By the end of 2027, the total cost of dry eye treatments is anticipated to reach over USD 6.6 billion across the globe.

The laser treatment is expected to cause the problems with dry eyes as the after results. Therefore, a rise in laser procedures is anticipated to boost the growth of the market. After having laser eye surgery, up to 95% of patients may develop dry eyes, that occur when the eyes produce fewer tears. Furthermore, the market growth is also expected to grow on the account of higher use of eye drops, followed by rise in geriatric population worldwide. It is commonly found more among aged population, as it is a disease of the tear film, and ocular surface that requires regular treatment and checks.


Dry Eye Syndrome Market Size

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of dry eye syndrome is evaluated at USD 6.75 billion.

The global dry eye syndrome market size was worth around USD 6.4 billion in 2025 and is set to register a CAGR of around 6.1%, exceeding USD 11.57 billion revenue by 2035.

North America dry eye syndrome market will secure around 40.8% share by 2035, driven by a high number of dry eye sufferers and increasing use of eye drops.

Key players in the market include Lumenis Be Ltd., Johnson & Johnson Services Inc., Alcon Vision LLC, Allergan (AbbVie), Novartis AG, Allostera Pharma Inc., I-Med Pharma Inc., Acadia Pharmaceutical Inc., Otsuka Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Ltd.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos